Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Responses to Alectinib in ALK-rearranged Papillary Renal Cell Carcinoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Responses to Alectinib in ALK-rearranged Papillary Renal Cell Carcinoma.
Responses to Alectinib in ALK-rearranged Papillary Renal Cell Carcinoma. Eur Urol. 2018 07; 74(1):124-128.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antineoplastic Agents
Carbazoles
Carcinoma, Renal Cell
Female
Humans
Kidney Neoplasms
Male
Oncogene Proteins, Fusion
Piperidines
Protein Kinase Inhibitors
authors with profiles
Ravi Salgia
Jonathan Chung